4/A

FORM 4/A SUBMISSION

Company: Eloxx Pharmaceuticals, Inc.
Filed: February 23, 2018
Period of Report: December 20, 2017
Accession Number: 0001209191-18-012960

View Document ↗ View on SEC.gov ↗